产品详情
In vitro | DMSO | 81 mg/mL (191.79 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (4.73 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.68 mL | 118.39 mL | 236.78 mL |
0.5 mM | 4.74 mL | 23.68 mL | 47.36 mL |
1 mM | 2.37 mL | 11.84 mL | 23.68 mL |
5 mM | 0.47 mL | 2.37 mL | 4.74 mL |
*The above data is based on the productmolecular weight 422.33. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A15843 |
---|---|
M. Wt | 422.33 |
Formula | C19H17Cl2N3O2S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 774549-97-2 |
Synonyms | KM-11060, KM11060 |
SMILES | O=S(N1CCN(C2=CC=NC3=CC(Cl)=CC=C23)CC1)(C4=CC=C(Cl)C=C4)=O |
产品标签
Product Questions
Product Questions
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf…
Dabrafenib (GSK2118436A)
Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂,具有V600E突变,目前正在临床试验中。
NVP-BHG712
NVP-BHG712是EphB4激酶的选择性抑制剂,在体外对EphB4的选择性超过40多种其他激酶(包括FGFR3)。
Dabigatran ethyl ester
Dabigatran ethyl ester是一种新兴的口服抗凝剂,是凝血酶活性的直接抑制剂。